Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Galbraith

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
Nature Communications|December 31, 2024
Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsidsTaisuke Furusho, Ranjan Das, Hideyuki Hakui, et al.
AIDS (London, England)|January 6, 1999
Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: a randomized, longitudinal studyB F Stanton, X Li, J Kahihuata, et al.
Lancet (London, England)|November 29, 1980
Teaching communicable disease epidemiologyR T Mayon-White, N S Galbraith, R J Hart, et al.
Lancet (London, England)|April 26, 1980
Epidemiology and clinical practiceE D Acheson, D J Barker, N J Blacklock, et al.
British Journal of Cancer|June 2, 2011
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapyC R Garrett, L L Siu, A El-Khoueiry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumorsD J Jonker, L S Rosen, M B Sawyer, et al.
Emerging Infectious Diseases|April 26, 2022
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021Julie R Harris, Daniel Owusu, Kevin O'Laughlin, et al.
American Journal of Preventive Medicine|February 21, 2012
The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive ServicesHelen B Chin, Theresa Ann Sipe, Randy Elder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2021
Coronavirus Disease 2019 (COVID-19) Mitigation Efforts and Testing During an In-Person Training Event-Uganda, 12-29 October 2020Rebecca L Laws, Sam Biraro, Wilford Kirungi, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Nature Communications|December 31, 2024
Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsidsTaisuke Furusho, Ranjan Das, Hideyuki Hakui, et al.
AIDS (London, England)|January 6, 1999
Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: a randomized, longitudinal studyB F Stanton, X Li, J Kahihuata, et al.
Lancet (London, England)|November 29, 1980
Teaching communicable disease epidemiologyR T Mayon-White, N S Galbraith, R J Hart, et al.
Lancet (London, England)|April 26, 1980
Epidemiology and clinical practiceE D Acheson, D J Barker, N J Blacklock, et al.
British Journal of Cancer|June 2, 2011
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapyC R Garrett, L L Siu, A El-Khoueiry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumorsD J Jonker, L S Rosen, M B Sawyer, et al.
Emerging Infectious Diseases|April 26, 2022
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021Julie R Harris, Daniel Owusu, Kevin O'Laughlin, et al.
American Journal of Preventive Medicine|February 21, 2012
The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive ServicesHelen B Chin, Theresa Ann Sipe, Randy Elder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2021
Coronavirus Disease 2019 (COVID-19) Mitigation Efforts and Testing During an In-Person Training Event-Uganda, 12-29 October 2020Rebecca L Laws, Sam Biraro, Wilford Kirungi, et al.
Pageof 18